Literature DB >> 20824409

Hyperbaric oxygen effect on MMP-9 after a vascular insult.

Francis J Cummins1, Laurie J Gentene.   

Abstract

Matrix metalloproteinease-9 (MMP-9) is involved in a host of processes. Many of its processes are physiologically beneficial as well as detrimental. The over-expression of this enzyme has been implicated as a contributory factor to some of the sequalae associated with cerebral ischemia, cell death, non-healing wounds, traumatic brain injury, aneurysms, and plaque instability in atherosclerosis. Several studies have examined the effect of hyperbaric oxygen (HBO) on MMP-9 expression. Because this proteinase is involved in both chronic and acute pathology, we wanted to investigate an acute expression model and see if, and how quickly, its expression would respond to HBO therapy. Our patient was scheduled to have elective surgery with an overnight stay followed by a series of HBO exposures. The patient served as her own control. An MMP-9 and urine pH was obtained prior to surgery to establish a baseline. On days 1, 3, and 4 post-op, samples were obtained before and after hyperbaric exposure. The patient was exposed to 100% O2 at 2.5 ATA for 60 min during each treatment for 5 days. The patient's MMP-9 values were dramatically elevated after surgery as compared to the baseline readings. The percentage increase from baseline was 400%. Our patient showed a significant reduction in MMP-9 expression after each hyperbaric exposure with the greatest decrease seen on post-op day 1 and subsequent exposures showing slightly less expression. Reduction in MMP-9 expression ranged from 46% on day 1 to 30% on post-op day 4. This case study suggests that if done relatively soon after a vascular or tissue insult, HBO can reduce MMP-9 expression. Chronic vascular pathologies, such as atherosclerotic plaque and aneurysms where over-expression of MMP-9 may result in acute coronary syndrome (ACS) or cerebral vascular accidents (CVAs), may be mitigated by a series of HBO treatments that reduce MMP-9 expression. Causality and/or contributory effects of MMP-9 expression in both pathologic and physiologic processes needs to be further elucidated. The understanding of how HBO therapy modulates these may provide an additional insight into mechanisms and future potential therapies for pathologic conditions such as those described above.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824409     DOI: 10.1007/s12265-010-9221-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  33 in total

1.  Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris.

Authors:  Mohsen Sharifi; Wassim Fares; Isam Abdel-Karim; J Michael Koch; Joseph Sopko; Dale Adler
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

2.  Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.

Authors:  Toshiaki Aoki; Toshihisa Sumii; Tatsuro Mori; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

Review 3.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

4.  Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells.

Authors:  Zheng-Rong Peng; Wei-Hong Zhong; Juan Liu; Ping-Tian Xiao
Journal:  Undersea Hyperb Med       Date:  2010 May-Jun       Impact factor: 0.698

5.  Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS.

Authors:  J A Buras; G L Stahl; K K Svoboda; W R Reenstra
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

6.  Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes.

Authors:  Hui-Hsin Wang; Hsi-Lung Hsieh; Cheng-Ying Wu; Chi-Chin Sun; Chuen-Mao Yang
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

7.  alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy.

Authors:  Renata Alleva; Marco Tomasetti; Davide Sartini; Monica Emanuelli; Emanuele Nasole; Ferruccio Di Donato; Battista Borghi; Lory Santarelli; Jiri Neuzil
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

8.  In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization.

Authors:  Anna L Sander; Dirk Henrich; Claus M Muth; Ingo Marzi; John H Barker; Johannes M Frank
Journal:  Wound Repair Regen       Date:  2009 Mar-Apr       Impact factor: 3.617

9.  Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen.

Authors:  Robert P Ostrowski; Vikram Jadhav; Wanqiu Chen; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2010

10.  Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.

Authors:  Mushfiquddin Khan; Yeong-Bin Im; Anandakumar Shunmugavel; Anne G Gilg; Ramanpreet K Dhindsa; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2009-11-04       Impact factor: 8.322

View more
  3 in total

1.  Repetitive long-term hyperbaric oxygen treatment (HBOT) administered after experimental traumatic brain injury in rats induces significant remyelination and a recovery of sensorimotor function.

Authors:  Klaus Kraitsy; Muammer Uecal; Stefan Grossauer; Lukas Bruckmann; Florentina Pfleger; Stefan Ropele; Franz Fazekas; Gerda Gruenbacher; Silke Patz; Markus Absenger; Christian Porubsky; Freyja Smolle-Juettner; Irem Tezer; Marek Molcanyi; Ulrike Fasching; Ute Schaefer
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

2.  The Effect of Hyperbaric Oxygen Therapy on Functional Impairments Caused by Ischemic Stroke.

Authors:  Emily R Rosario; Stephanie E Kaplan; Sepehr Khonsari; Garrett Vazquez; Niyant Solanki; Melanie Lane; Hiriam Brownell; Sheila S Rosenberg
Journal:  Neurol Res Int       Date:  2018-10-09

3.  Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox".

Authors:  Deborah Fratantonio; Fabio Virgili; Alessandro Zucchi; Kate Lambrechts; Tiziana Latronico; Pierre Lafère; Peter Germonpré; Costantino Balestra
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.